BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38063999)

  • 1. Inherited BRCA1 and RNF43 pathogenic variants in a familial colorectal cancer type X family.
    Chan JM; Clendenning M; Joseland S; Georgeson P; Mahmood K; Joo JE; Walker R; Como J; Preston S; Chai SM; Chu YL; Meyers AL; Pope BJ; Duggan D; Fink JL; Macrae FA; Rosty C; Winship IM; Jenkins MA; Buchanan DD
    Fam Cancer; 2024 Mar; 23(1):9-21. PubMed ID: 38063999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNF43 pathogenic Germline variant in a family with colorectal cancer.
    Mikaeel RR; Young JP; Li Y; Poplawski NK; Smith E; Horsnell M; Uylaki W; Tomita Y; Townsend AR; Feng J; Zibat A; Kaulfuß S; Müller C; Yigit G; Wollnik B; Scott H; Rawlings L; Henry D; Vakulin C; Dubowsky A; Price TJ
    Clin Genet; 2022 Jan; 101(1):122-126. PubMed ID: 34541672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors-A Cohort Study.
    Aswath K; Welch J; Gubbi S; Veeraraghavan P; Avadhanula S; Gara SK; Dikoglu E; Merino M; Raffeld M; Xi L; Kebebew E; Klubo-Gwiezdzinska J
    Front Endocrinol (Lausanne); 2021; 12():653401. PubMed ID: 34326811
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Martín-Morales L; Garre P; Lorca V; Cazorla M; Llovet P; Bando I; García-Barberan V; González-Morales ML; Esteban-Jurado C; de la Hoya M; Castellví-Bel S; Caldés T
    Cancer Prev Res (Phila); 2021 Feb; 14(2):185-194. PubMed ID: 33115781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.
    Yurgelun MB; Kulke MH; Fuchs CS; Allen BA; Uno H; Hornick JL; Ukaegbu CI; Brais LK; McNamara PG; Mayer RJ; Schrag D; Meyerhardt JA; Ng K; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Syngal S
    J Clin Oncol; 2017 Apr; 35(10):1086-1095. PubMed ID: 28135145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNF43 mutation analysis in serrated polyposis, sporadic serrated polyps and Lynch syndrome polyps.
    van Herwaarden YJ; Koggel LM; Simmer F; Vink-Börger EM; Dura P; Meijer GA; Nagengast FM; Hoogerbrugge N; Bisseling TM; Nagtegaal ID
    Histopathology; 2021 Apr; 78(5):749-758. PubMed ID: 33098683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriers.
    Georgeson P; Pope BJ; Rosty C; Clendenning M; Mahmood K; Joo JE; Walker R; Hutchinson RA; Preston S; Como J; Joseland S; Win AK; Macrae FA; Hopper JL; Mouradov D; Gibbs P; Sieber OM; O'Sullivan DE; Brenner DR; Gallinger S; Jenkins MA; Winship IM; Buchanan DD
    Gut; 2021 Nov; 70(11):2138-2149. PubMed ID: 33414168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation.
    Yan HHN; Lai JCW; Ho SL; Leung WK; Law WL; Lee JFY; Chan AKW; Tsui WY; Chan ASY; Lee BCH; Yue SSK; Man AHY; Clevers H; Yuen ST; Leung SY
    Gut; 2017 Sep; 66(9):1645-1656. PubMed ID: 27329244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of germline variants with pathogenic potential in 48 patients with familial colorectal cancer by using whole exome sequencing.
    Singh AK; Talseth-Palmer B; Xavier A; Scott RJ; Drabløs F; Sjursen W
    BMC Med Genomics; 2023 Jun; 16(1):126. PubMed ID: 37296477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers.
    Fennell LJ; Clendenning M; McKeone DM; Jamieson SH; Balachandran S; Borowsky J; Liu J; Kawamata F; Bond CE; Rosty C; Burge ME; Buchanan DD; Leggett BA; Whitehall VLJ
    Fam Cancer; 2018 Jan; 17(1):63-69. PubMed ID: 28573495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on genetic predisposition to colorectal cancer and polyposis.
    Valle L; de Voer RM; Goldberg Y; Sjursen W; Försti A; Ruiz-Ponte C; Caldés T; Garré P; Olsen MF; Nordling M; Castellvi-Bel S; Hemminki K
    Mol Aspects Med; 2019 Oct; 69():10-26. PubMed ID: 30862463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case Review: Whole-Exome Sequencing Analyses Identify Carriers of a Known Likely Pathogenic Intronic
    Alenezi WM; Fierheller CT; Revil T; Serruya C; Mes-Masson AM; Foulkes WD; Provencher D; El Haffaf Z; Ragoussis J; Tonin PN
    Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare germline variants in the AXIN2 gene in families with colonic polyposis and colorectal cancer.
    Chan JM; Clendenning M; Joseland S; Georgeson P; Mahmood K; Walker R; Como J; Joo JE; Preston S; Hutchinson RA; Pope BJ; Metz A; Beard C; Purvis R; Arnold J; Vijay V; Konycheva G; Atkinson N; Parry S; Jenkins MA; Macrae FA; Rosty C; Winship IM; Buchanan DD
    Fam Cancer; 2022 Oct; 21(4):399-413. PubMed ID: 34817745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome Patients.
    Jansen AM; Geilenkirchen MA; van Wezel T; Jagmohan-Changur SC; Ruano D; van der Klift HM; van den Akker BE; Laros JF; van Galen M; Wagner A; Letteboer TG; Gómez-García EB; Tops CM; Vasen HF; Devilee P; Hes FJ; Morreau H; Wijnen JT
    PLoS One; 2016; 11(6):e0157381. PubMed ID: 27300758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A practical screening strategy for Lynch syndrome and Lynch syndrome mimics in colorectal cancer.
    Yao ZG; Lv BB; Jing HY; Su WJ; Li JM; Fan H; Zhao MQ; Qin YJ; Sun XC
    J Cancer Res Ther; 2021 Jul; 17(3):790-796. PubMed ID: 34269315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teenage-Onset Colorectal Cancers in a Digenic Cancer Predisposition Syndrome Provide Clues for the Interaction between Mismatch Repair and Polymerase δ Proofreading Deficiency in Tumorigenesis.
    Schamschula E; Kinzel M; Wernstedt A; Oberhuber K; Gottschling H; Schnaiter S; Friedrichs N; Merkelbach-Bruse S; Zschocke J; Gallon R; Wimmer K
    Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population-based study of hereditary non-polyposis colorectal cancer: evidence of pathologic and genetic heterogeneity.
    Warden G; Harnett D; Green J; Wish T; Woods MO; Green R; Dicks E; Rahman P; Zhai G; Parfrey P
    Clin Genet; 2013 Dec; 84(6):522-30. PubMed ID: 23278430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of germline variants in cancer-associated genes in young adults with colorectal cancer.
    Mikaeel RR; Young JP; Li Y; Smith E; Horsnell M; Uylaki W; Tapia Rico G; Poplawski NK; Hardingham JE; Tomita Y; Townsend AR; Feng J; Zibat A; Kaulfuß S; Müller C; Yigit G; Wollnik B; Price TJ
    Genes Chromosomes Cancer; 2022 Feb; 61(2):105-113. PubMed ID: 34761457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline variation in the oxidative DNA repair genes NUDT1 and OGG1 is not associated with hereditary colorectal cancer or polyposis.
    Mur P; Jemth AS; Bevc L; Amaral N; Navarro M; Valdés-Mas R; Pons T; Aiza G; Urioste M; Valencia A; Lázaro C; Moreno V; Puente XS; Stenmark P; Warpman-Berglund U; Capellá G; Helleday T; Valle L
    Hum Mutat; 2018 Sep; 39(9):1214-1225. PubMed ID: 29900613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The implications of BRCA loss of heterozygosity (LOH) and deficient mismatch repair gene (dMMR) expression in the breast cancer of a patient with both inherited breast and ovarian cancer syndrome (BRCA2) and Lynch syndrome (MLH1).
    Sorscher S; Ansley K; Delaney SD; Ramkissoon S
    Breast Cancer Res Treat; 2020 Apr; 180(2):511-514. PubMed ID: 32040686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.